Huron Gastro

What Huron Gastro does

Huron Gastro is a private, physician-owned gastroenterology practice operating as Huron Gastroenterology Associates PC, headquartered at 5300 Elliott Dr. in Ypsilanti, Michigan. The practice delivers digestive disease diagnosis and treatment to adult patients through seven locations across the Ann Arbor/Ypsilanti and Metro Detroit corridor, staffed by 30 providers including gastroenterologists and physician assistants with subspecialty expertise in advanced endoscopy, hepatology, inflammatory bowel disease, and general gastroenterology. The clinical service catalog spans routine endoscopic procedures (colonoscopy, EGD, flexible sigmoidoscopy) through advanced interventional work (EUS, ERCP, EMR, RFA), specialized diagnostics (capsule endoscopy, BRAVO 96-hour pH monitoring, Fibroscan/Velacur liver elastography, anorectal and esophageal manometry), and therapeutic interventions (hemorrhoid banding, PEG placement, paracentesis, pneumatic balloon dilation, fecal microbiota transplant).

The practice runs on three revenue streams: fee-for-service clinical care billed through insurance, facility fees from its endoscopy centers and hospital surgical suites, and clinical research payments from pharmaceutical and CRO sponsors. Since 2009, Huron Gastro has participated in 53 FDA-approved interventional and non-interventional studies with sponsors including Takeda, AbbVie, Eli Lilly, Gilead, Janssen, Genentech, Pfizer, Bristol-Myers Squibb, and Madrigal Pharmaceuticals, achieving top U.S. recruiting site status for its last two Phase 3 trials. Patient acquisition combines a referring physician network (via MiHIN Referral Plus, telephone, and fax) with direct-to-consumer channels including a website, patient portal, and telehealth consultations. Core operational infrastructure is anchored by a co-location partnership with Trinity Health Ann Arbor Hospital, which provides IRB oversight, a 24/7 research pharmacy, IATA-certified specimen handling, and access to diagnostic services.

Name

Huron Gastro

Legal name

Huron Gastroenterology Associates PC

Website

https://hurongastro.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

Huron Gastro is a physician-owned private gastroenterology practice in Michigan that diagnoses and treats adult digestive disorders across seven Ann Arbor and Metro Detroit locations, staffed by 30 providers offering colonoscopy, advanced endoscopy, liver elastography, and clinical research services.

Ownership category

akta.pro rank

Product category

Gastroenterology Services

NAICS

Ambulatory Health Care Services (621), Outpatient Care Centers (6214), Freestanding Ambulatory Surgical and Emergency Centers (621493)

akta.pro primary industry

General Gastroenterology (HLAKAEAA)

akta.pro secondary industries

Advanced Endoscopy (ERCP/EUS/Interventional) (HLAKAEAC), Inflammatory Bowel Disease (IBD) Care (HLAKAEAD), Digestive Oncology (GI Cancer Care) (HLAKAEAF), Pancreaticobiliary Disorders (HLAKAEAG), Endoscopy & GI Procedure Centers (HLAFAIAE)

Keywords

• Gastroenterology services
• Endoscopic procedures
• Hepatology services
• Clinical research trials
• Digestive health care

Headquarters

HQ city

Ypsilanti

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Services: Fee-for-service medical care including office consultations, diagnostic procedures (colonoscopy, EGD, EUS, ERCP, etc.), and therapeutic treatments. Revenue generated through insurance billing and patient payments.
2. Clinical Research: Participation in FDA-approved clinical trials for pharmaceutical companies and research organizations. Receives compensation from sponsors for study participation, patient enrollment, and research activities.
3. Facility Fees: Separate facility fees charged for procedures performed at their endoscopy centers and hospital surgical suites, distinct from professional fees.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Huron Gastro is a private multi-location gastroenterology practice delivering diagnostic and therapeutic digestive care to adult patients across seven facilities in the Ann Arbor and Metro Detroit areas. The practice provides standard endoscopic procedures (colonoscopy, EGD, flexible sigmoidoscopy), advanced interventional procedures (EUS, ERCP, EMR, RFA), and specialized diagnostics (capsule endoscopy, BRAVO pH monitoring, liver elastography) supported by on-site endoscopy suites, infusion rooms, and an active clinical research program.

Product overview

Huron Gastro is a gastroenterology practice offering a comprehensive range of digestive health diagnostic and therapeutic procedures. The practice operates as a multi-location provider with 30 providers delivering care across seven facilities in the Ann Arbor and Metro Detroit areas. Core services include standard endoscopic procedures such as Colonoscopy, Esophagogastroduodenoscopy (EGD), and Flexible Sigmoidoscopy, alongside advanced interventional procedures including Endoscopic Ultrasonography (EUS), Endoscopic Mucosal Resection (EMR), ERCP, and Radiofrequency Ablation (RFA). Specialized diagnostic services include Capsule Endoscopy, BRAVO pH Monitoring, and Ultrasound-based Liver Elastography (using Fibroscan and Velacur technologies). The practice also offers therapeutic procedures such as Pneumatic Balloon Dilation, PEG tube placement, Paracentesis, and Liver Biopsy. Telehealth consultations are available for referring physicians. The practice maintains active clinical research programs in gastroenterology and hepatology conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Colonoscopy Visual examination of the colon and rectum using a flexible endoscope to diagnose and treat conditions such as polyps, cancer, and inflammatory bowel disease; offered to adult patients for screening, surveillance, and diagnostic indications.
• Esophagogastroduodenoscopy (EGD) Upper endoscopy procedure examining the esophagus, stomach, and duodenum to diagnose and treat symptoms such as heartburn, reflux, ulcers, and gastrointestinal bleeding.
• Flexible Sigmoidoscopy Endoscopic examination of the lower colon and rectum, available with or without sedation, used to evaluate lower GI symptoms.
• Endoscopic Ultrasonography (EUS) Endoscopic procedure combining ultrasound imaging to evaluate the pancreas, bile ducts, and surrounding tissues; used for cancer staging, cyst evaluation, and biopsy of abdominal lesions.
• Endoscopic Mucosal Resection (EMR) Specialized technique removing precancerous and early cancerous tissue from the gastrointestinal tract, most commonly used in the esophagus and colon, avoiding the need for surgery.
• Capsule Endoscopy Small capsule containing a camera that the patient swallows to capture thousands of pictures of the small intestine, used to identify sources of unexplained GI bleeding, Crohn's disease, and small bowel tumors.
• BRAVO 96-Hour Esophageal pH Monitoring Minimally invasive test attaching a small pH monitoring device to the esophageal wall during endoscopy to measure acid reflux frequency and duration over 4 days.
• Endoscopic Retrograde Cholangiopancreatography (ERCP) Specialized procedure examining and treating ducts of the liver, gallbladder, and pancreas; used to remove bile duct stones, dilate strictures, and place stents.
• Radiofrequency Ablation (RFA) Technique using controlled superficial burns to eliminate abnormal tissue, primarily used to treat dysplastic Barrett's esophagus and early stage esophageal cancer.
• Ultrasound-based Liver Elastography Non-invasive test using ultrasound technology (Fibroscan or Velacur) to estimate liver fibrosis, scarring, and fat deposition (steatosis) to optimize treatment plans, often replacing liver biopsy.
• ColoCleanse Bowel preparation solution provided to patients in preparation for colonoscopy procedures.
• Hemorrhoid Banding Non-surgical treatment procedure for internal hemorrhoids offered in the office setting.
• Anorectal Manometry Diagnostic test measuring anorectal muscle function to evaluate fecal incontinence, constipation, and other anorectal disorders.
• Fecal Microbiota Transplant (FMT) Procedure transplanting fecal bacteria to treat recurrent C. difficile infection and other qualifying conditions.
• Pneumatic Balloon Dilation Procedure using a balloon to stretch and partially tear the esophageal sphincter muscle to treat achalasia and improve swallowing.
• Percutaneous Endoscopic Gastrostomy (PEG) Placement of a feeding tube through the skin of the abdomen into the stomach for patients who have difficulty eating by mouth.
• Liver Biopsy Procedure to obtain liver tissue for analysis to determine the cause and extent of liver disease.
• Paracentesis Procedure removing excess fluid (ascites) from the abdominal cavity, often due to cirrhosis, heart failure, kidney failure, or cancer.
• Pouchoscopy Examination of the lining of a small intestinal pouch for inflammation, abnormal growths, or tissue, available with or without sedation.
• Esophageal Manometry Test measuring esophageal muscle contractions and function to evaluate swallowing disorders.
• Ileoscopy Endoscopic examination of the ileum, available with or without sedation.
• Fit3D Scan Body composition scanning technology used to support wellness and metabolic assessments.
• Telehealth Consultations Virtual healthcare consultations provided via telehealth technology for patient evaluations, referrals, and follow-up care.
• Clinical Research Program FDA-approved gastroenterology and hepatology clinical trials for pharmaceutical sponsors, delivered by a research team of 9 gastroenterologists, 1 hepatologist, 1 PA, and 4 research coordinators, using Trinity Health Ann Arbor Hospital's IRB and infrastructure.

Quantifiable outcome

• Top recruiting site in the United States for last two Phase 3 clinical studies participated in
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

19 partnerships are on record, tiered core and minor.

• Trinity Health Ann Arbor HospitalcoreStrategic or Co-development PartnerHuron Gastro is a private gastroenterology practice on the campus of Trinity Health St. Joseph Mercy Ann Arbor. The practice leverages proximity to the hospital for access to state-of-the-art equipment, clinical research infrastructure, phlebotomy, specimen processing (IATA certified staff), -20/-70 specimen freezers, laboratory tests, pathology, radiology, EKGs, and research pharmacy services. The hospital's research pharmacy provides 24/7 IP receipt and accounting, dispensing, compounding, and drug storage. The practice uses Trinity Health Ann Arbor Hospital's IRB (#1) for human subject research approvals.
• Takeda Development Center Americas, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Huron Gastro participating in Vedolizumab Phase 4 study (Triple Combination Therapy in High Risk Crohn's Disease, Vedolizumab-4006) and other Takeda-sponsored trials including VISIBLE maintenance and long-term open-label extension studies.
• AbbVie, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in AbbVie-sponsored trials including ABT-494 (upadacitinib) for ulcerative colitis induction and maintenance therapy (M14-234 and M14-675 studies) and long-term extension study (M14-533).
• Eli Lilly / QuintilesminorStrategic or Co-development PartnerClinical trial sponsor. Participating in Eli Lilly-sponsored mirikizumab Phase 3 trials for ulcerative colitis (Lucent 1, 2, and 3 studies) and LY3074828 (SERENITY) for Crohn's disease.
• Gilead Sciences, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in Gilead-sponsored selonsertib Phase 3 studies for NASH patients with bridging fibrosis (F3) and compensated cirrhosis (GS-US-384-1943 and GS-US-384-1944).
• Janssen R&D / ParexelminorStrategic or Co-development PartnerClinical trial sponsor. Participating in ustekinumab (Stelara) Phase 3 trials for Crohn's disease (UNITI 2, IMUNITI) and ulcerative colitis (UNIFI).
• Genentech, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in BFKB8488A Phase 2 study for NASH (GC41033 BANFF) and HALO Patient Registry for Barrett's Esophagus ablation.
• Pfizer / ICON Clinical ResearchminorStrategic or Co-development PartnerClinical trial sponsor. Participating in tofacitinib (CP-690,550) Phase 3 trials for ulcerative colitis (OCTAVE induction and maintenance, OCTAVE-Extension).
• Madrigal PharmaceuticalsminorStrategic or Co-development PartnerClinical trial sponsor. Participating in resmetirom (MGL-3196) Phase 3 study for NAFLD (MAESTRO-NAFLD-1).
• MiHIN (Michigan Health Information Network)coreTechnology or IntegrationHuron Gastro uses MiHIN Referral Plus, a secure system for sending and receiving referrals throughout Michigan. The application functions similarly to Outlook email and supports efficient care coordination workflows. Meets Blue Cross Blue Shield of Michigan Patient Centered Medical Home capabilities requirements.
• Alimentiv, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in Takeda EXPLORER study for Crohn's disease (triple combination therapy with vedolizumab, adalimumab, and methotrexate).
• Intercept Pharma, Inc. / Syneos HealthminorStrategic or Co-development PartnerClinical trial sponsor. Participating in obeticholic acid Phase 3 study for NASH cirrhosis (REGENERATE, 747-304) and long-term study (747-303).
• Assembly Biosciences, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in oral AMT-101 Phase 2a study for ulcerative colitis and ABI-M201-101 Phase 1b study for ulcerative colitis with fecal microbiota transplant.
• Bristol-Myers Squibb CompanyminorStrategic or Co-development PartnerClinical trial sponsor. Participating in BMS-986165 Phase 2 study for Crohn's disease (LATTICE, IM011023).
• Janssen R&D / Johnson & Johnson Services, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in ustekinumab Seavue study comparing efficacy of ustekinumab to adalimumab in biologic-naive Crohn's disease subjects.
• Salix PharmaceuticalsminorStrategic or Co-development PartnerClinical trial sponsor. Participating in budesonide foam Phase 3 studies for ulcerative proctitis and proctosigmoiditis.
• UCB, Inc. / PRA International, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in SECURE non-interventional post-marketing registry for certolizumab pegol (Cimzia) in Crohn's disease.
• BARRX Medical, Inc.minorStrategic or Co-development PartnerClinical trial sponsor. Participating in HALO Patient Registry for Ablation of Barrett's Esophagus.
• AAHC (Accreditation Association for Hospitals/Health Systems)minorOthersHuron Gastro displays AAHC accreditation logo on their website, indicating affiliation with the Accreditation Association for Hospitals/Health Systems.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• GI Alliance: Largest PE-backed (Welsh Carson) gastroenterology platform in the U.S. with multi-state ASC and clinical research operations — directly comparable to Huron Gastro as a multi-specialty GI group with research and endoscopy center infrastructure.
• United Digestive: PE-backed (Kohlberg & Company) Southeast GI platform combining clinical care, endoscopy centers, and clinical research — directly comparable to Huron Gastro in specialty mix, ASC ownership, and active pharma-sponsored trial programs.
• One GI: PE-backed (Webster Equity Partners) GI practice platform with embedded research and ancillary services; closely mirrors Huron Gastro's combination of general GI, advanced endoscopy, and a multi-location clinical model.
• Gastro Health: PE-backed (Olympus Partners) multi-site GI group operating across multiple states with infusion and endoscopy centers; comparable as a large, multi-specialty private gastroenterology practice.
• Borland Groover: Large, independent, multi-location Florida gastroenterology practice with in-house clinical research and a freestanding endoscopy center — closely analogous to Huron Gastro's integrated clinical/research/ASC model.
• Digestive Health Associates of Texas (DHAT): Large Texas-based independent GI group with multiple endoscopy centers and clinical research activity; comparable regional multi-site GI practice model.
• Dayton Gastroenterology: Mid-size regional gastroenterology group in Ohio with endoscopy centers and clinical research participation; comparable scale, regional footprint, and research mix.
• Illinois Gastroenterology Group: Large multi-specialty GI practice in Illinois offering general and advanced endoscopy services across multiple sites — similar structure and patient mix to Huron Gastro.

Broad incumbents

• Michigan Medicine (University of Michigan Health): Major academic health system in the same Ann Arbor market; broader portfolio but competes directly for advanced GI and hepatology referrals and clinical trial patients in the local catchment area.
• Trinity Health Michigan: Hospital system and core strategic partner of Huron Gastro; operates competing GI service lines at its Ann Arbor, Chelsea, Brighton, and Livonia hospitals, making it both enabler and competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/hurongastro
• Facebookfacebook.com/hurongastro
• LinkedInlinkedin.com/company/huron-gastroenterology

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Huron Gastro